Preparing Community Hospitals for CAR T’s Expansion
By Kevin J. Land
November 5, 2026
By choosing where to participate and working with specialist partners, community hospitals can bring more of the CAR T patient journey closer to home
6 min read
False
Advertisement
Development & Clinical
Who Funds Biotech Shapes What Gets Built
By Kathryn Wighton, James Strachan
November 4, 2026
Stella Vnook explains why broader representation at the investment table can strengthen biotech, expand support for women-led companies, and accelerate innovation in women’s health
9 min read
BMS Details Patient Death in Zola-Cel Multiple Sclerosis Trial
November 3, 2026
The company also reported early efficacy and safety data from the Phase I Breakfree-2 study
2 min read
America Votes, China Plans
By James Strachan
November 3, 2026
China sets out its stall for global biopharmaceutical preeminence as the US faces further uncertainty over research funding and regulation
23 min read
Can Immunopeptidomics Redefine Cancer Immunotherapy Development?
By Katherine Tran
November 3, 2026
Immunopeptidomics is helping researchers identify tumor-presented antigens that could inform the development of targeted cell therapies and personalized cancer vaccines
3 min read
Strategic Development of Complex Oral Therapies
By Rebecca Coutts
November 2, 2026
Early characterization and manufacturing planning can help developers choose the right formulation strategy for complex oral therapies
5 min read
Off-the-Shelf CAR T Shows Early Signal in Progressive Multiple Sclerosis
November 2, 2026
Phase I data show B-cell depletion and mostly stable or improved disability scores, but the uncontrolled study remains small and follow-up is limited
2 min read
Staying the Course: Sitting Down With Mike Cooke
By Henry Thomas, James Strachan
October 29, 2026
AmacaThera Co-Founder and CEO Mike Cooke reflects on the long road from academic discovery to a potential new treatment for post-operative pain
9 min read
Live Roundtable: What Is the Biggest Bottleneck Holding Back Cell and Gene Therapy?
October 23, 2026
Industry leaders debate the manufacturing, regulatory, financial, and commercial barriers preventing advanced therapies from reaching more patients
1 min read
Can Clinical Trials Collect Less Data Without Compromising Safety?
By Mouj Hijazi
October 22, 2026
Rob DiCicco discusses how FDA–industry collaboration is helping sponsors rethink safety reporting, selective safety data collection, and pragmatic clinical trial design.
5 min read
